Previous close | 3,040.00 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 3,040.00 - 3,040.00 |
52-week range | 2,671.39 - 4,344.00 |
Volume | |
Avg. volume | 2 |
Market cap | 534.952B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 27.47 |
EPS (TTM) | 110.66 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | 32.83 (1.08%) |
Ex-dividend date | 08 May 2024 |
1y target est | N/A |
ResMed ( NYSE:RMD ) Third Quarter 2024 Results Key Financial Results Revenue: US$1.20b (up 7.2% from 3Q 2023). Net...
ResMed Inc. ( NYSE:RMD ) investors will be delighted, with the company turning in some strong numbers with its latest...
Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2024. Third Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 7% to $1.2 billion; up